In Vitro Activities of Amphotericin B, Terbinafine, and Azole Drugs against Clinical and Environmental Isolates of Aspergillus terreus Sensu Stricto

被引：11

作者：

Fernandez, Mariana S. ^{[1
]}

Rojas, Florencia D. ^{[1
]}

Cattana, Maria E. ^{[1
]}

Sosa, Maria de los Angeles ^{[1
]}

Iovannitti, Cristina A. ^{[2
]}

Lass-Floerl, Cornelia ^{[3
]}

Giusiano, Gustavo E. ^{[1
]}

机构：

[1] Univ Nacl Nordeste, Inst Med Reg, Dept Micol, Resistencia, Argentina

[2] Univ Buenos Aires, Fac Med, CONICET UBA, Ctr Micol,IMPAM, Buenos Aires, DF, Argentina

[3] Med Univ Innsbruck, Dept Hyg Microbiol & Social Med, A-6020 Innsbruck, Austria

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2015年 / 59卷 / 06期

关键词：

EPIDEMIOLOGIC CUTOFF VALUES; FUNGICIDAL ACTIVITIES; MIC DISTRIBUTIONS; VORICONAZOLE; INFECTIONS; ITRACONAZOLE; ANTIFUNGAL; RESISTANCE; SPP; CLSI;

D O I：

10.1128/AAC.00045-15

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The antifungal susceptibilities of 40 clinical and environmental isolates of A. terreus sensu stricto to amphotericin B, terbinafine, itraconazole, and voriconazole were determined in accordance with CLSI document M38-A2. All isolates had itraconazole and voriconazole MICs lower than epidemiologic cutoff values, and 5% of the isolates had amphotericin B MICs higher than epidemiologic cutoff values. Terbinafine showed the lowest MICs. No significant differences were found when MICs of clinical and environmental isolates were compared.

引用

页码：3619 / 3622

页数：4

共 39 条

[1] Susceptibility of environmental versus clinical strains of pathogenic Aspergillus [J].

Araujo, Ricardo ;

Pina-Vaz, Cidalia ;

Rodrigues, Acacio Goncalves .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (01) :108-111

[2] Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network [J].

Baddley, John W. ;

Marr, Kieren A. ;

Andes, David R. ;

Walsh, Thomas J. ;

Kauffman, Carol A. ;

Kontoyiannis, Dimitrios P. ;

Ito, James I. ;

Balajee, S. Arunmozhi ;

Pappas, Peter G. ;

Moser, Stephen A. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (10) :3271-3275

[3] Epidemiology of Aspergillus terreus at a university hospital [J].

Baddley, JW ;

Pappas, PG ;

Smith, AC ;

Moser, SA .

JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (12) :5525-5529

[4] A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates [J].

Blum, G. ;

Perkhofer, S. ;

Grif, K. ;

Mayr, A. ;

Kropshofer, G. ;

Nachbaur, D. ;

Kafka-Ritsch, R. ;

Dierich, M. P. ;

Lass-Floerl, C. .

CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (12) :1146-1151

[5] Potential basis for amphotericin B resistance in Aspergillus terreus [J].

Blum, Gerhard ;

Perkhofer, Susanne ;

Haas, Hubertus ;

Schrettl, Markus ;

Wuerzner, Reinhard ;

Dierich, Manfred P. ;

Lass-Floerl, Cornelia .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (04) :1553-1555

[6] New Insight into Amphotericin B Resistance in Aspergillus terreus [J].

Blum, Gerhard ;

Hoertnagl, Caroline ;

Jukic, Emina ;

Erbeznik, Thomas ;

Puempel, Thomas ;

Dietrich, Hermann ;

Nagl, Markus ;

Speth, Cornelia ;

Rambach, Guenter ;

Lass-Floerl, Cornelia .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (04) :1583-1588

[7]

Bosco Borgeat M. E., 2011, MANUAL METODOS MOL E, P164

[8]

Chamilos G, 2006, HAEMATOL-HEMATOL J, V91, P986

[9]

Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI

[10] Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi [J].

Diekema, DJ ;

Messer, SA ;

Hollis, RJ ;

Jones, RN ;

Pfaller, MA .

JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (08) :3623-3626

← 1 2 3 4 →